Work

Efficacy and safety of Mirikizumab in the treatment of moderate to severe inflammatory bowel diseases: a systematic review and updated meta-analysis

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Inflammopharmacology

DOI: 10.1007/s10787-025-01971-z

Authors: Joel Gabin Konlack Mekontso, Joseph Yvan Bena Nnang, Samuel G. J. Fodop, Bishoy I. B. Elkoumes, Guy Loic Nguefang Tchoukeu, Anifatou B. Kortim, Ticha B. T. Tembi, Akil Olliverre, Jarin Prasa, John Trillo

Institutions: New York City Health and Hospitals Corporation, Université de Yaoundé I, Catholic University of Cameroon, Texas Tech University Health Sciences Center, University of Bamenda, Emory University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414616588

FWCI: 0.152

Cites: 38

Cited by: 1

Related to: 10